| 1 |
21220496 | Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924. | 2011 Jan |
1 |
| 2 |
20153189 | SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors. | 2010 Mar 1 |
1 |
| 3 |
20545947 | Design of potent IGF1-R inhibitors related to bis-azaindoles. | 2010 Aug |
1 |
| 4 |
18572407 | Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors. | 2008 Jul 15 |
1 |
| 5 |
18763755 | Discovery and evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an orally efficacious inhibitor of insulin-like growth factor-1 receptor kinase with broad spectrum in vivo antitumor activity. | 2008 Oct 9 |
1 |